- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
ComMedica unveils I-PACS
Web-based clinical IT software vendor ComMedica has released its next-generation link between medical imaging and RIS. The software package, called Integrated PACS application (I-PACS), is designed to manage the entire process of patient care, from
Web-based clinical IT software vendor ComMedica has released its next-generation link between medical imaging and RIS. The software package, called Integrated PACS application (I-PACS), is designed to manage the entire process of patient care, from booking appointments to delivery of diagnosis, within a single Web-based, open standards architecture. The company is now preparing to install the system in the U.K. for Global Diagnostics, a mobile imaging service. The goal is to allow patients to be referred for scans immediately, thereby alleviating some of the burden on the U.K. National Health Services. Specialists will also view images at an earlier stage, potentially leading to faster diagnosis and consequent treatment.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
